DENVER–(BUSINESS WIRE)–MedPharm Holdings, a leading medical cannabis manufacturer, R&D laboratory, and compounding facility, won awards in two categories at the third annual LeafLink List 2020 competition, an annual cannabis award series that is a celebration of cannabis brands, products, and retailers, and how they are shaping the cannabis industry.
MedPharm won the Top Selling Cartridge award for their BATCH cartridge, and, for the second year in a row, won the Top Selling Tincture award for their Aliviar 20:1 tincture.
“Today, thanks to our amazing retail partners and our team at MedPharm, we are truly honored to be selected for these two top awards by the industry leading national wholesale cannabis industry platform, LeafLink,” Albert Gutierrez, CEO of MedPharm, says.
LeafLink’s awards confirm the consumer preference for MedPharm’s two popular products. BATCH is an 80-95 percent THC cartridge, available in indica, sativa or as a hybrid, 100 percent pure, uncut, terp reintroduction CO2 nug-run distillate. Medical cannabis patients particularly like the consistent dosage of the Aliviar 20:1 tincture, which is designed as a flavorless, orderless tincture that is easier on the stomach, with no alcohol, co-solvents, fillers or cutting agents.
“It’s crazy to think we have only been selling in the mature Colorado cannabis market for less than three years, and have been able to make so many accomplishments with these and other products we have been rolling out year after year,” Gutierrez says. “Our team here at MedPharm continues to grow and we are excited to see what the next three years, and beyond, will bring to our loyal customers,” Gutierrez says. “We are very grateful for the recognition by LeafLink, and for the support of our products from the cannabis community. As always, we will strive to bring our customers more on-target products that can help them live better, more fulfilled, and healthier lives. Our goal is to improve the human condition.”
LeafLink is a national wholesale platform used in the cannabis industry that connects over 1,700 cannabis brands with over 5,600 licensed retailers in 26 territories across North America. Founded in 2016, LeafLink has been focused on streamlining the cannabis supply chain, building tools that directly address and empower the cannabis community.
About MedPharm:
MedPharm has a 15,000-square-foot manufacturing, research and development laboratory and cannabis processing facility in Denver, Colorado. Since beginning operations in 2017, MedPharm has grown to a staff of 34 people. The company provides cannabis pharmaceutical-type products in a certified current Good Manufacturing Practices (cGMP) and Good Agricultural Practices (GAP) facility that includes cultivation, pre-formulation, formulation development, small scale commercial manufacturing, analytical method development and validation, routine quality control analysis and stability studies. MedPharm creates pharmaceutical-grade dosage forms and produced ingredients utilizing pharmaceutical technology to be used in the delivery of cannabis compounds. MedPharm got the first cannabis research license issued to the state of Colorado in October, 2018. MedPharm Research also has a pending application for a federal research Bulk Manufacturer license to provide cannabis and cannabis dosage forms for research purposes. More information can be found about MedPharm at: www.medpharmholdings.com.
Contacts
Tim Mathisen
720-697-7555
info@medpharmholdings.com